- Severe coronary artery disease complicating Takayasu arteritis
-
Chung JI, Kim YS, Chung BI, Choi JW, Choi IS, Ahn SW, Shin EK
- KMID: 1698027
- Korean J Intern Med.
- 1991 Dec;41(6):836-840.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Self-Injurious Behavior Through Behavior Therapy
-
Chung BI, Kim JS, Yang JS, Kang BS
- KMID: 1683357
- J Korean Pediatr Soc.
- 1990 May;33(5):585-597.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Expected Next-Generation Drugs Under Development in Relation to Voiding Symptoms
-
Chung KJ, Chung BI
- KMID: 2387169
- Int Neurourol J.
- 2017 Jun;21(2):97-101.
- doi: 10.5213/inj.1734928.464
New drug development is a high-risk venture, but if successful, will bring great revenues to those willing to accept the risk. In the field of urology, in particular for lower... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Treatment of Acute Occlusion Complicating Percutaneous Transluminal Coronary Angioplasty
-
Kim YS, Chung JI, Chung BI, Choi JW, Choi IS, Ahn SW, Shin EK
- KMID: 2093324
- Korean Circ J.
- 1991 Oct;21(5):932-939.
- doi: 10.4070/kcj.1991.21.5.932
Management of unstable angina has evolved progressively. Although coronary angioplasty has recently shown to be relatively safe and effective treatment strategy for unstable angina, aute occlusion due to intracoronary thrombus... -
- CITED
-
- Close
- SHARE
-
- Close
- Practice Pattern of Redo Varicocelectomy for Recurrent Varicocele according to Type of Initial Treatment: Retrospective Analysis of a United States-Based Insurance Claims Database
-
Park HK, Min GE, Chung KJ, Li S, Choi WS, Chung BI
- KMID: 2516722
- World J Mens Health.
- 2021 Jul;39(3):559-565.
- doi: 10.5534/wjmh.190170
Purpose: The objective of this study was to investigate the type of redo varicocelectomy according to the initial surgery type using a large population of USA insurance data. Materials and Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Relating Prognosis in Chromophobe Renal Cell Carcinoma to the Chromophobe Tumor Grading System
-
Weinzierl , Thong AE, McKenney J, Jeon SH, Chung BI
- KMID: 1885603
- Korean J Urol.
- 2014 Apr;55(4):239-244.
- doi: 10.4111/kju.2014.55.4.239
PURPOSE: The chromophobe subtype of renal cell carcinoma (chRCC) has generally been associated with a better prognosis than the clear cell type; however, debate continues as to absolute prognosis as... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for Postoperative Hemorrhage After Partial Nephrectomy
-
Jung S, Min GE, Chung BI, Jeon SH
- KMID: 1988447
- Korean J Urol.
- 2014 Jan;55(1):17-22.
- doi: 10.4111/kju.2014.55.1.17
PURPOSE: To evaluate the frequency and clinical characteristics of postoperative hemorrhage as a complication of partial nephrectomy. MATERIALS AND METHODS: The demographics, physical statistics, tumor size, R.E.N.A.L. nephrometry score, operative method,... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Postprostatectomy Incontinence Requiring Anti-incontinence Surgery After Radical Prostatectomy for Prostate Cancer: A Retrospective Population-Based Analysis
-
Kim JH, Jeong IG, Khandwala YS, Hernandez-Boussard T, Brooks JD, Chung BI
- KMID: 2520877
- Int Neurourol J.
- 2021 Sep;25(3):263-270.
- doi: 10.5213/inj.2040296.148
Purpose: This study aimed to examine the prevalence of surgery for postprostatectomy incontinence (PI) following minimally invasive surgery compared to conventional open surgery for prostate cancer. Methods: This retrospective cohort study... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
-
Kim JH, Shim SR, Khandwala Y, Giudice FD, Sorensen S, Chung BI
- KMID: 2506418
- World J Mens Health.
- 2020 Oct;38(4):535-544.
- doi: 10.5534/wjmh.190046
Purpose: Although five-alpha reductase inhibitor (5-ARI) is one of standard treatment for benign prostatic hyperplasia (BPH) or alopecia, potential complications after 5-ARI have been issues recently. This study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Docetaxel Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Prostate Cancer Cells via Epigenetic Gene Regulation by Enhancer of Zeste Homolog 2
-
Lee WH, Kim SC, Kim SH, Yoon JH, Moon KH, Cheon SH, Kwon T, Kim YM, Park JW, Lee SH, Lee JM, Park S, Chung BI
- KMID: 2543311
- World J Mens Health.
- 2023 Jul;41(3):649-658.
- doi: 10.5534/wjmh.220073
Purpose Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity and its ability to induce apoptosis in cancer cells while sparing most normal... -
- CITED
-
- Close
- SHARE
-
- Close
